NephroGenex Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NephroGenex Inc announces closing of initial public offering
NephroGenex Inc:Says the closing of its initial public offering of 3,100,000 shares of common stock at a public offering price of $12.00 per share for total gross proceeds of $37,200,000 before underwriting discounts.In addition, it has granted the underwriter a 45-day option to purchase up to an additional 465,000 shares of common stock from NephroGenex to cover over-allotments, if any.Says its stock is listed on The NASDAQ Capital Market under the trading symbol NRX.Aegis Capital Corp. acted as sole book-running manager for the offering.
Latest Developments for NephroGenex Inc
- Share this
- Digg this